Loading
Loading
Bio-Fabricated Structural Proteins Cannot Be Produced at Textile-Industry Scale or Cost
Recombinant structural proteins — particularly spider silk (spidroins) — offer mechanical properties superior to any synthetic fiber (strength-to-weight ratio exceeding Kevlar, toughness exceeding steel), but after 15+ years of development and over $330M in investment, Bolt Threads could not produce them at prices competitive with even premium textiles. Spider silk proteins are long, repetitive, and aggregation-prone, making them exceptionally difficult to express in microbial hosts at high yields. The fermentation process is sensitive to subtle variations in temperature, pH, and protein viscosity — any deviation can ruin a batch. Even when protein is successfully produced, post-fermentation spinning must replicate the hierarchical nanostructure of natural spider silk to achieve its mechanical properties, a process that remains poorly understood.
The textile industry is the third-largest polluter globally, and petroleum-derived synthetic fibers (polyester, nylon) account for ~60% of global fiber production. Bio-fabricated structural proteins could replace synthetics with biodegradable, high-performance alternatives — spider silk for technical textiles, collagen for medical materials, elastin for tissue engineering. Bolt Threads' parallel mycelium leather product (Mylo) also stalled at commercial scale, suggesting the bio-fabricated materials industry faces a systematic "valley of death" between lab-proven properties and industrial production economics. Japan's Spiber has made the most progress (dedicated factories, partnerships with The North Face), but still operates at relatively small scale with premium pricing far above commodity synthetics.
Bolt Threads engineered yeast to produce recombinant spider silk protein and developed wet-spinning processes to form fibers. However, spidroin expression in yeast yields are low because the large, repetitive protein sequences are prone to recombination (the yeast's DNA repair machinery clips the repetitive silk genes) and aggregation during folding. Purification from fermentation broth is expensive because spidroins must be solubilized in chaotropic agents, adding cost and complexity. The spinning process is the deeper challenge: natural spider silk achieves its properties through a precisely controlled liquid crystalline phase transition as the protein passes through the spider's spinneret — the protein goes from a highly concentrated, disordered solution to an aligned, crystalline fiber over millimeters. Industrial spinning processes that replicate this phase transition at production speeds have not been developed. Spiber's approach uses a different protein (brewed protein based on fibroin-like sequences, not true spidroins), achieving lower mechanical performance but better processability.
Engineered expression systems (cell-free synthesis, plant-based expression) that avoid microbial recombination of repetitive silk genes could dramatically increase yields. Biomimetic spinning processes that replicate the pH gradient, ionic environment, and shear profile of natural spider spinnerets could achieve the hierarchical nanostructure responsible for silk's mechanical properties without requiring the protein to be identical to natural spidroins. Computational protein design that identifies minimal sequence motifs required for silk-like assembly could enable shorter, less repetitive proteins that are easier to produce. Alternative structural proteins (mussel byssus, hagfish slime thread, insect resilin) may offer better production economics for specific applications.
A team could prototype a biomimetic spinning device that imposes controlled pH and shear gradients on a recombinant silk protein solution, characterizing fiber structure as a function of spinning parameters. Alternatively, a team could use computational protein design tools (Rosetta, AlphaFold) to identify minimal beta-sheet motifs that self-assemble into silk-like structures, then test expression in E. coli. Relevant disciplines: materials science, bioengineering, mechanical engineering, computational biology.
Bolt Threads ($330M raised, stock crashed 94% in two months) is the most prominent case, but the structural protein production challenge is universal. Spiber (Japan, ~$800M raised) is furthest along but has pivoted to more processable proteins at the expense of mechanical performance. Kraig Biocraft (transgenic silkworms) and AMSilk (Germany, fibroin-based) take biological rather than fermentation-based approaches. Related: chemistry-synbio-commodity-molecule-cost-floor (same fermentation cost-floor challenge but for small molecules rather than structural proteins — the protein case is worse because proteins aggregate and misfold).
LUXEPLACE, "Why Did Bolt Threads' Valuation Crash 94%?", 2024, https://luxeplace.com/once-famous-for-spider-silk-and-mushroom-leather-why-did-bolt-threads-valuation-crash-94-in-two-months/; C&EN, "Delivering on spider silk's promise," 2017, https://cen.acs.org/articles/95/i8/Delivering-spider-silks-promise.html; BoF, "Bolt Threads Pauses Operations of Leather-Alternative Mylo," 2023; accessed 2026-02-20